MEDIGEN VACCINE BIOLOGICS
The high-end vaccine is a biotech new drug company that develops and mass-produces vaccines and biological agents. It uses cell culture technology and develops viral vaccines and biosimilar drugs through the International Cooperation Alliance. Based on Taiwan, the company will give priority to Taiwan's demanded products as the development target, providing innovative medical products to protect the health and safety of the whole people. At the same time, we hope to become a research and development and mass production center in the Asia-Pacific region, and then look to the world to protect all human beings from the threat of many diseases.
MEDIGEN VACCINE BIOLOGICS
Industry:
Biotechnology Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.medigenvac.com
Status:
Active
Contact:
02-7745-0830
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Apache
Similar Organizations
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Current Employees Featured
Official Site Inspections
http://www.medigenvac.com Semrush global rank: 364.68 K Semrush visits lastest month: 159.51 K
- Host name: 223.27.34.173
- IP address: 223.27.34.173
- Location: Taipei Taiwan
- Latitude: 25.0478
- Longitude: 121.5318
- Timezone: Asia/Taipei
More informations about "Medigen Vaccine Biologics"
Medigen Vaccine Biologics Corp.
We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.See details»
About Us-Medigen Vaccine Biologics Corp.
We have PIC/S GMP certified cell culture commercial mass production capabilities, and target global and regional infectious diseases to develop novel vaccines and affordable biosimilar …See details»
Vaccine | 基亞生物科技股份有限公司／Medigen Biotech Corp.
With modern cell-cultivation platform and extensive international partnerships, MVC develops novel cell-based vaccines and affordable biosimilars to prevent regional infectious disease in …See details»
MVC partners with the WHO C-TAP Initiative as The First Private ...
Taipei, TAIWAN, Aug 29, 2023 - In a significant move towards equitable global vaccine distribution, Medigen Vaccine Biologics Corp. (MVC, TPEx 6547.TWO) announces an out …See details»
Medigen Vaccine Biologics Corp | LinkedIn
A leading Taiwanese biotechnology company with COVID-19 and EV vaccines advancing toward commercialization | Established in 2012, Medigen Vaccine Biologics Corp (MVC) is a …See details»
Medigen Vaccine Biologics Corporation - Wikipedia
The Medigen Vaccine Biologics Corporation (MVC; traditional Chinese: 高端疫苗生物製劑; simplified Chinese: 高端疫苗生物制剂; pinyin: Gāoduān Yìmiáo Shēngwù Zhìjì) is a …See details»
Medigen Vaccine Biologics - Crunchbase Company Profile
Contact Email [email protected] Phone Number 02-7745-0830 The high-end vaccine is a biotech new drug company that develops and mass-produces vaccines and biological agents.See details»
Member Profile - TRPMA Official Website
Oct 12, 2012 · Medigen Vaccine Biologics Corporation (MVC) is a biopharmaceutical company focusing on the development and production of vaccines and biologics.See details»
MVC COVID-19 vaccine - Wikipedia
On 26 October 2021, the World Health Organization (WHO) selected Medigen vaccine as one of its Solidarity Trial Vaccines. The trial is designed to rapidly evaluate the efficacy and safety of …See details»
Dynavax and Medigen Announce Collaboration to Develop a …
Jul 23, 2020 · MVC is a cell-based biopharmaceutical company focusing on the development and production of vaccines and biologics. MVC’s business partners include US NIH, US CDC, …See details»
2022 Annual Report - medigenvac.com
MVC COVID-19 vaccine was also sponsored by the international organization "Consortium for Epidemic Preparedness Innovations (CEPI)" to conduct the third booster immunization mixed …See details»
Medigen Vaccine Biologics COVID-19 Vaccine Adjuvanted with …
Jan 25, 2021 · MVC's pipeline includes enterovirus EV71 vaccine, dengue vaccine, influenza quadrivalent vaccine which all have entered late clinical stage. MVC's large-scale production …See details»
Medigen's MVC-COV1901 Selected for WHO COVID-19 Solidarity …
TAIPEI, Oct. 27, 2021 /PRNewswire/ -- Medigen Vaccine Biologics Corp (MVC) vaccine candidate, MVC-COV1901, has been recommended by an independent vaccine prioritisation …See details»
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And
TAIPEI, Oct. 15, 2021 /CNW/ -- The Lancet Respiratory Medicine, one of the world's best-known peer-reviewed medical journals has published Medigen Vaccine Biologics (MVC) data from its...See details»
Medigen's COVID-19 Vaccine Combined with Dynavax's CpG 1018 …
Oct 13, 2020 · MVC's large-scale production facility is state of the art and adherent to international PIC/s and GMP requirements. For more information, visit www.medigenvac.com.See details»
2021 Annual Report - medigenvac.com
International organization "Consortium for Epidemic Preparedness Innovations (CEPI)" to conduct the third booster immunization mixed trial of MVC vaccines, mRNA vaccines, and adenovirus …See details»
Latest news LATEST NEWS - medigenvac.com
We aim to become one of the leading pharmaceutical companies and to do all in our power to help prevent infectious diseases.See details»
Medigen Vaccine Biologics Announces Launch of Its COVID-19 …
MVC's pipeline includes EV71 vaccine, dengue vaccine, quadrivalent influenza vaccine and COVID-19 vaccine which all have entered late clinical stage. MVC's large-scale production …See details»
Medigen Vaccine Biologics Announces Launch of Its COVID-19 …
Aug 23, 2021 · MVC is a biopharmaceutical company using cell-based technologies to develop novel vaccines and biosimilars. MVC's pipeline includes EV71 vaccine, dengue vaccine, …See details»
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And …
TAIPEI, Oct. 15, 2021 /PRNewswire/ -- The Lancet Respiratory Medicine, one of the world's best-known peer-reviewed medical journals has published Medigen Vaccine Biologics (MVC) data …See details»